Biomerica (NASDAQ:BMRA) Share Price Passes Below 200 Day Moving Average – Here’s What Happened

Shares of Biomerica, Inc. (NASDAQ:BMRA) passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $2.81 and traded as low as $2.33. Biomerica shares last traded at $2.39, with a volume of 15,858 shares changing hands.

Analysts Set New Price Targets

Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Biomerica in a research note on Tuesday, October 14th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company has an average rating of “Sell”.

Biomerica Price Performance

The firm has a market capitalization of $7.22 million, a price-to-earnings ratio of -2.57 and a beta of 0.11. The business’s fifty day simple moving average is $2.50 and its 200 day simple moving average is $2.81.

Biomerica (NASDAQ:BMRA) last released its quarterly earnings data on Wednesday, January 14th. The company reported ($0.45) earnings per share (EPS) for the quarter. The company had revenue of $1.21 million for the quarter. Biomerica had a negative return on equity of 83.73% and a negative net margin of 90.29%.

About Biomerica

Biomerica, Inc is a developer, manufacturer and marketer of in vitro diagnostic tests for clinical diagnostic, life science research and food safety applications. The company’s product portfolio includes enzyme-linked immunosorbent assays (ELISAs), lateral flow immunoassays, point-of-care devices and specialty reagents designed to aid in the detection and monitoring of gastrointestinal, metabolic and autoimmune conditions. Biomerica’s diagnostics are used by hospitals, clinical and reference laboratories, and research institutions seeking solutions for early disease detection and patient management.

Key offerings from Biomerica include serological tests for celiac disease and gluten intolerance, quantitative assays for colorectal cancer screening markers such as M2-PK, and a range of point-of-care kits for metabolic monitoring.